 Enveric Biosciences NASDAQ:ENVB issued a letter to shareholders from its CEO Joseph Tucker, highlighting the milestones of 2021 and the strategic plans for 2022. 2021 was a foundational year that set the stage for our company by assembling a talented and expert team to execute our strategy for the future, said Tucker in a statement. 